Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to...
Read more
NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), has been granted...
Read more
Axion BioSystems, the global leader in microelectrode array (MEA) technology, introduces the next generation of MEA platforms, Maestro Pro and...
Read more
GlaxoSmithKline plc, announced the publication of full results from the phase III studies for mepolizumab in chronic obstructive pulmonary disease...
Read more
ESSA Pharma Inc. , a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of...
Read more
Adamas Pharmaceuticals, Inc. announced that the U.S. FDA has approved GOCOVRI extended release capsules (previously ADS-5102) for treatment of dyskinesia...
Read more
Sanofi announced that the U.S. FDA granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin...
Read more
Jazz Pharmaceuticals plc and ImmunoGen, Inc. announced that the companies have entered into a collaboration and option agreement granting Jazz...
Read more
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy...
Read more
The Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
